Mr. Wong Fook Choy Sunny
Non-Executive Chairman and Independent Director
Current Board in FY2026 annual report; not assumed all roles held in earlier fiscal yearsThe business, the people and the ownership behind UGHealthcare.
Business overview
UG Healthcare manufactures and distributes hand protection products under its UNIGLOVES brand. Its global distribution network also markets non-glove hygiene products and healthcare-related ancillary products.
Listed security
Board & management
Five current directors, manufacturingManagingDirector and CompanySecretary. Both Lee brothers are JointCEOs with separate FinanceDirector/ChiefOperatingOfficer roles. Gillian Ng Lee Eng name retained as reported in this latest report; no unsupported legal-name-change inference. Earlier departed directors are not listed as current.
Non-Executive Chairman and Independent Director
Current Board in FY2026 annual report; not assumed all roles held in earlier fiscal yearsJoint CEO, Executive Director and Finance Director
Current Board in FY2026 annual report; not assumed all roles held in earlier fiscal yearsJoint CEO, Executive Director and Chief Operating Officer
Current Board in FY2026 annual report; not assumed all roles held in earlier fiscal yearsIndependent and Non-Executive Director
Current Board in FY2026 annual report; not assumed all roles held in earlier fiscal yearsIndependent and Non-Executive Director
Current Board in FY2026 annual report; not assumed all roles held in earlier fiscal yearsManaging Director
Manufacturing Division; not Company Board directorCOMPANY SECRETARY
Company Secretary in FY2026 annual reportRoles listed in ANNUAL REPORT 2026; current appointments are not independently verified.
Holdings
Twenty registered holders, five substantial holders, three register context facts, one Zen nominee allocation and two director-interest rows. Register18September2026 differs from30June2026 fiscal year-end and21July2026 director follow-up.
Common deemed block374729122 held through Zen/Raydion is reported by SimAiCheng and both JointCEOs, not independent ownership. Printed source percentages retained even when ordinary half-up rounding differs.
Direct: 156,537,713 shares; deemed: 141,318,282 shares; total: 297,855,995 shares (47.75%).
As recorded in the Register of Substantial Shareholders; shares As reported at 2026-09-18Direct: 76,873,127 shares; deemed: –; total: 76,873,127 shares (12.32%).
As recorded in the Register of Substantial Shareholders; shares As reported at 2026-09-18Direct: –; deemed: 374,729,122 shares; total: 374,729,122 shares (60.07%).
As recorded in the Register of Substantial Shareholders; shares As reported at 2026-09-18Direct: 2,845,063 shares; deemed: 374,729,122 shares; total: 377,574,185 shares (60.53%).
As recorded in the Register of Substantial Shareholders; shares As reported at 2026-09-18Direct: 2,217,089 shares; deemed: 374,729,122 shares; total: 376,946,211 shares (60.42%).
As recorded in the Register of Substantial Shareholders; shares As reported at 2026-09-18511,318,761 shares (81.96%).
Registered/depository top20 at18September2026 As reported at 2026-09-18623,825,811 ordinary shares; treasury shares and subsidiary holdingsNIL
Shareholder statistics18September2026 As reported at 2026-09-1839.12%
Source-defined public hands at18September2026 As reported at 2026-09-18141,318,282 shares registered under CGS International Securities (Singapore) Pte. Ltd.
Subset of already-disclosed Zen deemed holding; not extra shares As reported at 2026-09-18Direct beginning/end:2,845,063/2,845,063; deemed374,729,122/374,729,122
Company ordinary shares;1July2025/30June2026; unchanged to21July2026 As reported at 2026-06-30Direct beginning/end:2,217,089/2,217,089; deemed374,729,122/374,729,122
Company ordinary shares;1July2025/30June2026; unchanged to21July2026 As reported at 2026-06-30Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.
Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-09-18 · PDF p. 168
| Registered holder | Interest | Shares / units | Source |
|---|---|---|---|
| CGS INTERNATIONAL SECURITIES SINGAPORE PTE LTD | 176,133,691 shares (28.23%). | PDF p. 1682026-09-18 | |
| ZEN UG PTE. LTD. | 156,537,713 shares (25.09%). | PDF p. 1682026-09-18 | |
| RAYDION DIRECT GLOBAL INC | 76,873,127 shares (12.32%). | PDF p. 1682026-09-18 | |
| PHILLIP SECURITIES PTE LTD | 18,759,486 shares (3.01%). | PDF p. 1682026-09-18 | |
| CITIBANK NOMINEES SINGAPORE PTE LTD | 12,572,253 shares (2.01%). | PDF p. 1682026-09-18 | |
| ANG CHIEN KIAT | 11,146,442 shares (1.79%). | PDF p. 1682026-09-18 | |
| OCBC SECURITIES PRIVATE LTD | 10,301,418 shares (1.65%). | PDF p. 1682026-09-18 | |
| HENG SIEW ENG | 7,759,766 shares (1.24%). | PDF p. 1682026-09-18 | |
| DBS NOMINEES PTE LTD | 6,337,247 shares (1.02%). | PDF p. 1682026-09-18 | |
| MAYBANK SECURITIES PTE. LTD. | 5,723,911 shares (0.92%). | PDF p. 1682026-09-18 | |
| IFAST FINANCIAL PTE LTD | 5,723,581 shares (0.92%). | PDF p. 1682026-09-18 | |
| MOOMOO FINANCIAL SINGAPORE PTE. LTD. | 3,969,717 shares (0.64%). | PDF p. 1682026-09-18 | |
| TIGER BROKERS (SINGAPORE) PTE. LTD. | 3,447,440 shares (0.55%). | PDF p. 1682026-09-18 | |
| LEE JUN YIH | 2,845,063 shares (0.46%). | PDF p. 1682026-09-18 | |
| JACK INVESTMENT PTE LTD | 2,784,800 shares (0.45%). | PDF p. 1682026-09-18 | |
| RAFFLES NOMINEES (PTE) LIMITED | 2,725,809 shares (0.44%). | PDF p. 1682026-09-18 | |
| LEE JUN LINN | 2,217,089 shares (0.35%). | PDF p. 1682026-09-18 | |
| WANG NAN ENG MARGARET | 2,078,999 shares (0.33%). | PDF p. 1682026-09-18 | |
| ZAINAL ABIDIN BIN HASSAN OR HANEL MATHIAS | 1,841,700 shares (0.29%). | PDF p. 1682026-09-18 | |
| LIM AND TAN SECURITIES PTE LTD | 1,539,509 shares (0.25%). | PDF p. 1682026-09-18 | |
Group structure
Eighteen current subsidiaries, two joint-venture schedule entities and one former-associate disclosure row. USA appears in both current subsidiary and historical associate schedules and is counted once as current legal entity. German former-associate rows are not carried forward fromFY2025 when no longer disclosed in this latest schedule.
Both Chinese legal names retained. German legal label preserves its two original printed fragments. Effective Company interests and intermediate holding routes are not multiplied or used to infer control.
| Company | Market | Ownership interest |
|---|---|---|
| N.S. Uni-Gloves Sdn. Bhd.Direct subsidiaryPDF p. 124 | Malaysia;Manufacturing of rubber gloves;2026:100%;2025:100% | |
| UG Global Resources Sdn. Bhd.Direct subsidiaryPDF p. 124 | Malaysia;Manufacturing of rubber gloves;2026:100%;2025:100% | |
| UG Glovetech Sdn. Bhd.Direct subsidiaryPDF p. 124 | Malaysia;Investment holding;2026:100%;2025:100% | |
| Unigloves (Singapore) Pte. Ltd.Direct subsidiaryPDF p. 124 | Singapore;Investment holding and business and management consultancy services;2026:100%;2025:100% | |
| UGHC Marketing Pte. Ltd.Direct subsidiaryPDF p. 124 | Singapore;Distribution of gloves and other medical disposables;2026:100%;2025:100% | |
| UG Engineering Sdn. Bhd.Direct subsidiaryPDF p. 124 | Malaysia;Investment holding;2026:100%;2025:100% | |
| UG Healthcare Sdn. Bhd.Direct subsidiaryPDF p. 125 | Malaysia;Investment holding;2026:100%;2025:100% | |
| Indigo Teguh Sdn. Bhd.Direct subsidiaryPDF p. 125 | Malaysia;Investment holding;2026:100%;2025:100% | |
| Unigloves (UK) LimitedIndirect via Unigloves (Singapore) Pte. Ltd.PDF p. 125 | United Kingdom;Distribution of gloves and other medical disposables;2026:55%;2025:55% | |
| Unigloves Shanghai Co., Ltd.Indirect via Unigloves (Singapore) Pte. Ltd.PDF p. 125 | China;Distribution of gloves and other medical disposables;2026:100%;2025:100% | |
| Uni-Medical Healthcare LimitedIndirect via Unigloves (Singapore) Pte. Ltd.PDF p. 125 | Nigeria;Distribution of gloves and other medical disposables;2026:75%;2025:75% | |
| UGHC Brasil Importadora LTDAIndirect via Unigloves (Singapore) Pte. Ltd.PDF p. 125 | Brazil;Distribution of gloves and other medical disposables;2026:90%;2025:90% | |
| 优格 (成都) 国际贸易有限公司Indirect via Unigloves (Singapore) Pte. Ltd.PDF p. 125 | China;Distribution of gloves and other medical disposables;2026:100%;2025:100% | |
| 友利格 (苏州) 国际贸易有限公司Indirect via Unigloves (Singapore) Pte. Ltd.PDF p. 125 | China;Distribution of gloves and other medical disposables;2026:100%;2025:100% | |
| Unigloves GmbHIndirect via Unigloves (Singapore) Pte. Ltd.PDF p. 125 | Germany;Investment holding;2026:100%;2025:100% | |
| UG Healthcare (USA) Inc.Indirect via Unigloves (Singapore) Pte. Ltd.PDF p. 125 | United States;Distribution of gloves and other medical disposables;2026:75%;2025:75% | |
| Unigloves Arzt- und Klinikbedarf - Handelsgesellschaft mbHIndirect via Unigloves GmbHPDF p. 125 | Germany;Distribution of gloves and other medical disposables;2026:100%;2025:100% | |
| Unigloves (Ireland) LimitedIndirect via Unigloves (UK) LimitedPDF p. 125 | Ireland;Distribution of gloves and other medical disposables;2026:55%;2025:55% | |
| UG Healthcare (USA) Inc.Former associate; transitioned50% to75% subsidiary22January2025PDF p. 129 | United States;Distribution of gloves and other medical disposables;2026:–;2025:– | |
| UG Nitrex, S. L.Joint-venture schedule effective Company interest; via Unigloves (Singapore) Pte. Ltd.PDF p. 128 | Spain;Distribution of reusable gloves and disposables gloves;2026:50.0%;2025:50.0% | |
| Nitrex SASJoint-venture schedule effective Company interest; via UG Nitrex S. L.PDF p. 128 | France;Distribution of reusable gloves and disposables gloves;2026:22.5%;2025:22.5% | |
Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.
Senior executives
| Item | Value | Period / scope | Source |
|---|---|---|---|
| MS. WONG PEK WEE | Managing Director, Manufacturing Division | Key Management | PDF p. 18 |
Extracted from ANNUAL REPORT 2026 and checked against the cited pages; see the original report for full context.
Related parties, people & properties
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Interested Person Transactions | The Company confirms that there were no interested person transactions during the financial year under review. | Group, FY ended 30 June 2026 | PDF p. 79 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Bank guarantee given to third parties for utility supplies to a subsidiary | 2,457 $'000 | Group, 2026 (2025: 2,291) | PDF p. 147 |
| Corporate guarantee given to banks for bank facilities granted to subsidiaries | 116,894 $'000 | Company, 2026 (2025: 117,661) | PDF p. 147 |
| Total contingent liabilities | 2,457 2,291 116,894 117,661 | Group 2026/2025 then Company 2026/2025 | PDF p. 147 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Mr. Lee Jun Yih | 499,708 S$ | FY2026, Executive Director and Joint CEO; salary 280,000, other benefits 15,708, profit sharing 204,000 | PDF p. 69 |
| Mr. Lee Jun Linn | 501,763 S$ | FY2026; salary 280,023, other benefits 17,740, profit sharing 204,000 | PDF p. 69 |
| Mr. Law Cheong Yan | 35,000 S$ | FY2026; fees 35,000 | PDF p. 69 |
| Ms. Gillian Ng Lee Eng | 40,000 S$ | FY2026; fees 40,000 | PDF p. 69 |
| Mr. Wong Fook Choy Sunny | 45,000 S$ | FY2026; fees 45,000 | PDF p. 69 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Number of employees | 34 53 656 41 67 729 | Group, FY2026 (Mgmt 34, Executive 53, Non-Exec 656) and FY2025 (Mgmt 41, Executive 67, Non-Exec 729) | PDF p. 40 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Looking ahead (Letter to Shareholders) | Looking ahead, we are committed to | Joint CEO / Chairman letter, FY26 | PDF p. 4 |
Extracted from ANNUAL REPORT 2026 and checked against the cited pages; see the original report for full context.
Corporate information